{"id":"https://openalex.org/W6990993","doi":null,"title":"Epigenetic alterations and cancer: new targets for therapy.","display_name":"Epigenetic alterations and cancer: new targets for therapy.","alternate_titles":[],"publication_year":2007,"publication_date":"2007-10-01","ids":{"openalex":"https://openalex.org/W6990993","mag":"6990993","pmid":"https://pubmed.ncbi.nlm.nih.gov/17899489"},"language":"en","primary_location":{"id":"pmid:17899489","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17899489","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"IDrugs : the investigational drugs journal","raw_type":"Journal Article"},"parent_works":[],"lineage":["https://openalex.org/W6990993"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5065505740","display_name":"Andrew R. Allen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Andrew Allen","raw_affiliation_strings":["Pharmion Corp, 1700 Owens Street, Suite 205, San Francisco, CA 94158, USA. AAllen@pharmion.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmion Corp, 1700 Owens Street, Suite 205, San Francisco, CA 94158, USA. AAllen@pharmion.com","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5065505740"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.533,"has_fulltext":false,"cited_by_count":9,"citation_normalized_percentile":{"value":0.57049362,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"10","issue":"10","first_page":"709","last_page":"712"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10269","display_name":"Epigenetics and DNA Methylation","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10269","display_name":"Epigenetics and DNA Methylation","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11736","display_name":"Histone Deacetylase Inhibitors Research","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12820","display_name":"Chromatin Remodeling and Cancer","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/epigenetic-modifications","display_name":"epigenetic modifications","score":0.972000002861023},{"id":"https://openalex.org/keywords/cancer","display_name":"cancer","score":0.7239999771118164},{"id":"https://openalex.org/keywords/dna-methylation","display_name":"DNA methylation","score":0.9959999918937683},{"id":"https://openalex.org/keywords/chromatin-structure","display_name":"chromatin structure","score":0.8679999709129333},{"id":"https://openalex.org/keywords/histone-acetylation","display_name":"histone acetylation","score":0.800000011920929},{"id":"https://openalex.org/keywords/histone-deacetylase-inhibitors","display_name":"histone deacetylase inhibitors","score":0.9139999747276306},{"id":"https://openalex.org/keywords/hypomethylating-agents","display_name":"hypomethylating agents","score":0.968999981880188},{"id":"https://openalex.org/keywords/azacitidine","display_name":"azacitidine","score":0.9150000214576721},{"id":"https://openalex.org/keywords/vorinostat","display_name":"vorinostat","score":1.0},{"id":"https://openalex.org/keywords/tumor-suppressor-genes","display_name":"tumor suppressor","score":0.9589999914169312},{"id":"https://openalex.org/keywords/epigenetic-therapy","display_name":"epigenetic therapy","score":0.7799999713897705},{"id":"https://openalex.org/keywords/therapeutic-target","display_name":"therapeutic target","score":0.5849999785423279}],"concepts":[{"id":"https://openalex.org/C41091548","wikidata":"https://www.wikidata.org/wiki/Q26939","display_name":"Epigenetics","level":3,"score":0.8210270404815674},{"id":"https://openalex.org/C2776262904","wikidata":"https://www.wikidata.org/wiki/Q905901","display_name":"Vorinostat","level":5,"score":0.691760778427124},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.6749832630157471},{"id":"https://openalex.org/C114691636","wikidata":"https://www.wikidata.org/wiki/Q5031434","display_name":"Cancer epigenetics","level":5,"score":0.6700605154037476},{"id":"https://openalex.org/C2778305200","wikidata":"https://www.wikidata.org/wiki/Q174378","display_name":"Histone deacetylase","level":4,"score":0.6423371434211731},{"id":"https://openalex.org/C83640560","wikidata":"https://www.wikidata.org/wiki/Q180951","display_name":"Chromatin","level":3,"score":0.600072979927063},{"id":"https://openalex.org/C2780737395","wikidata":"https://www.wikidata.org/wiki/Q18353741","display_name":"Epigenetic therapy","level":5,"score":0.5974438786506653},{"id":"https://openalex.org/C64927066","wikidata":"https://www.wikidata.org/wiki/Q36293","display_name":"Histone","level":3,"score":0.5864888429641724},{"id":"https://openalex.org/C63016187","wikidata":"https://www.wikidata.org/wiki/Q17162664","display_name":"Epigenetic regulation of neurogenesis","level":5,"score":0.5652525424957275},{"id":"https://openalex.org/C190727270","wikidata":"https://www.wikidata.org/wiki/Q874745","display_name":"DNA methylation","level":4,"score":0.5489417314529419},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.531450629234314},{"id":"https://openalex.org/C167227067","wikidata":"https://www.wikidata.org/wiki/Q5113739","display_name":"Chromatin remodeling","level":4,"score":0.47567954659461975},{"id":"https://openalex.org/C2776202225","wikidata":"https://www.wikidata.org/wiki/Q3569101","display_name":"Histone deacetylase inhibitor","level":5,"score":0.4321839213371277},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.3019452691078186},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.2512809634208679},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.19288340210914612},{"id":"https://openalex.org/C150425827","wikidata":"https://www.wikidata.org/wiki/Q2560317","display_name":"Histone methyltransferase","level":4,"score":0.18806040287017822}],"mesh":[{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D004357","descriptor_name":"Drug Synergism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006655","descriptor_name":"Histone Deacetylases","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006655","descriptor_name":"Histone Deacetylases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D015972","descriptor_name":"Gene Expression Regulation, Neoplastic","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D016503","descriptor_name":"Drug Delivery Systems","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D018849","descriptor_name":"Controlled Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019175","descriptor_name":"DNA Methylation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D020868","descriptor_name":"Gene Silencing","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D044127","descriptor_name":"Epigenesis, Genetic","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:17899489","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17899489","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"IDrugs : the investigational drugs journal","raw_type":"Journal Article"},{"id":"mag:6990993","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17899489","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":26,"referenced_works":["https://openalex.org/W139723508","https://openalex.org/W1130143712","https://openalex.org/W1154069494","https://openalex.org/W1269699965","https://openalex.org/W1493302055","https://openalex.org/W1544995918","https://openalex.org/W1567844991","https://openalex.org/W1607046039","https://openalex.org/W1644961992","https://openalex.org/W1849835585","https://openalex.org/W1970365419","https://openalex.org/W1974201116","https://openalex.org/W1981876250","https://openalex.org/W1995976503","https://openalex.org/W2015483985","https://openalex.org/W2028425784","https://openalex.org/W2035640920","https://openalex.org/W2061933967","https://openalex.org/W2068672830","https://openalex.org/W2114975970","https://openalex.org/W2145126115","https://openalex.org/W2203404798","https://openalex.org/W2305449604","https://openalex.org/W2400413990","https://openalex.org/W2917546100","https://openalex.org/W4232709285"],"related_works":["https://openalex.org/W2411865681","https://openalex.org/W1819264890","https://openalex.org/W1558958593","https://openalex.org/W2041057224","https://openalex.org/W2000603503","https://openalex.org/W67322295","https://openalex.org/W2185729166","https://openalex.org/W2566411937","https://openalex.org/W2909403547"],"abstract_inverted_index":{"Over":[0],"the":[1,14,34,48,76,106,109,114,120,139],"last":[2],"two":[3],"decades,":[4],"preclinical":[5],"and":[6,16,26,51,69,94,133],"clinical":[7],"research":[8,126],"has":[9],"implicated":[10],"epigenetic":[11,143],"alterations":[12,27],"in":[13,28,56,105,119],"pathogenesis":[15],"progression":[17],"of":[18,36,38,79,111,116,122,131,142],"cancer.":[19],"Epigenetic":[20],"changes,":[21],"involving":[22],"both":[23],"DNA":[24,67,87],"methylation":[25],"chromatin":[29],"structure,":[30],"are":[31],"associated":[32],"with":[33,63],"inhibition":[35],"transcription":[37,78],"key":[39],"cell":[40,49,54,80],"regulatory":[41,81],"genes":[42,82],"that,":[43],"under":[44],"normal":[45,77],"conditions,":[46],"control":[47],"cycle":[50],"initiate":[52],"apoptotic":[53],"death":[55],"neoplastic":[57],"cells.":[58],"Drugs":[59],"have":[60,102],"been":[61,103],"developed":[62],"functional":[64],"effects,":[65],"including":[66],"hypomethylation":[68],"histone":[70,95],"acetylation,":[71],"that":[72],"serve":[73],"to":[74],"restore":[75],"(eg,":[83],"tumor":[84],"suppressor":[85],"genes).":[86],"hypomethylating":[88],"agents,":[89],"such":[90,98],"as":[91,99],"azacitidine":[92],"(Vidaza),":[93],"deacetylase":[96],"inhibitors":[97],"vorinostat":[100],"(Zolinza)":[101],"approved":[104],"US":[107],"for":[108],"treatment":[110],"cancer,":[112],"reinforcing":[113],"importance":[115],"these":[117,129],"pathways":[118],"biology":[121],"this":[123],"disease.":[124],"Current":[125],"involves":[127],"combining":[128],"classes":[130],"agents":[132],"identifying":[134],"new":[135],"drug":[136],"targets":[137],"within":[138],"growing":[140],"family":[141],"enzymes.":[144]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W6990993","counts_by_year":[{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-18T13:11:19.462570","created_date":"2016-06-24T00:00:00"}
